APA (7th ed.) Citation

E, L., NR, F., EW, S., RA, H., E, P., J, V., . . . LYC, C. (2026). Lenalidomide-Dexamethasone as an Effective and Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and Pharmacophenomic Study. American journal of hematology, 101(7), 1478. https://doi.org/10.1002/ajh.70309

Chicago Style (17th ed.) Citation

E, Leung, et al. "Lenalidomide-Dexamethasone as an Effective And Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical And Pharmacophenomic Study." American Journal of Hematology 101, no. 7 (2026): 1478. https://doi.org/10.1002/ajh.70309.

MLA (9th ed.) Citation

E, Leung, et al. "Lenalidomide-Dexamethasone as an Effective And Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical And Pharmacophenomic Study." American Journal of Hematology, vol. 101, no. 7, 2026, p. 1478, https://doi.org/10.1002/ajh.70309.